We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.27B
AUM Growth
-$287M
Cap. Flow
-$382M
Cap. Flow %
-30.07%
Top 10 Hldgs %
34.31%
Holding
428
New
73
Increased
98
Reduced
156
Closed
77

Top Buys

Rank Stock Value
1
CTRA
Coterra Energy
CTRA
+$26.5M
2
PFE icon
Pfizer
PFE
+$19.8M
3
SM icon
SM Energy
SM
+$19.7M
4
HD icon
Home Depot
HD
+$14M
5
ASML icon
ASML
ASML
+$11.5M

Top Sells

Rank Stock Value
1
EQT icon
EQT Corp
EQT
+$38.2M
2
DVN icon
Devon Energy
DVN
+$20.5M
3
JNJ icon
Johnson & Johnson
JNJ
+$18.4M
4
JPM icon
JPMorgan Chase
JPM
+$17.9M
5
ZWS icon
Zurn Elkay Water Solutions
ZWS
+$16.2M

Sector Composition

Rank Sector Weight
1 Energy 31.08%
2 Technology 12.45%
3 Healthcare 10.63%
4 Industrials 10.2%
5 Financials 10.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LKQ icon
301
LKQ Corp
LKQ
$6.58B
$215K 0.02%
+3,584
New +$202K
LRN icon
302
Stride
LRN
$3.69B
$213K 0.02%
6,392
-10,446
-62% -$361K
DHHCU
303
DELISTED
DiamondHead Holdings Corp. Unit
DHHCU
$197K 0.02%
20,000
– –
MIR.WS
304
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
$194K 0.02%
+77,500
New +$211K
RBAC.WS
305
DELISTED
RedBall Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordina
RBAC.WS
$184K 0.01%
+148,237
New +$219K
ROSS.WS
306
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
$162K 0.01%
177,888
+72,332
+69% +$72.7K
OPEN icon
307
Opendoor
OPEN
$3.69B
$151K 0.01%
10,684
-26,300
-71% -$486K
EOCW.WS
308
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$144K 0.01%
134,785
+54,418
+68% +$60.9K
CZOO
309
DELISTED
Cazoo Group Ltd
CZOO
$139K 0.01%
12
-23
-66% -$355K
SVFAW
310
DELISTED
SVF Investment Corp. Warrant
SVFAW
$137K 0.01%
105,500
+60,500
+134% +$80.2K
KAHC.WS
311
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
$132K 0.01%
132,535
+91,875
+226% +$95.4K
PEARW
312
DELISTED
Pear Therapeutics, Inc. Warrant
PEARW
$128K 0.01%
+213,551
New +$217K
HCVIW
313
DELISTED
Hennessy Capital Investment Corp. VI Warrant
HCVIW
$125K 0.01%
+156,464
New +$132K
VELO
314
DELISTED
Velocity Acquisition Corp. Class A Common Stock
VELO
$117K 0.01%
12,069
– –
FMIVW
315
DELISTED
Forum Merger IV Corporation Warrant
FMIVW
$111K 0.01%
135,062
+41,232
+44% +$43.3K
PV
316
DELISTED
Primavera Capital Acquisition Corporation
PV
$106K 0.01%
10,908
– –
PIIIW icon
317
P3 Health Partners Inc Warrant
PIIIW
$136K
$103K 0.01%
+97,700
New +$118K
APSG.WS
318
DELISTED
Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer
APSG.WS
$92K 0.01%
+71,500
New +$74.9K
PRPB.WS
319
DELISTED
CC Neuberger Principal Holdings II Redeemable warrants, each whole warrant exercisable for one Class
PRPB.WS
$89K 0.01%
+65,500
New +$74.1K
GSQD.WS
320
DELISTED
G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
GSQD.WS
$88K 0.01%
102,500
+72,500
+242% +$80.9K
WALDW icon
321
Waldencast PLC Warrant
WALDW
$4.48M
$79K 0.01%
+65,500
New +$69.8K
DSACW
322
DELISTED
Duddell Street Acquisition Corp. Warrant
DSACW
$79K 0.01%
+63,500
New +$70.7K
UEC icon
323
Uranium Energy
UEC
$4.71B
$65K 0.01%
+19,510
New +$75.1K
MOTV.WS
324
DELISTED
Motive Capital Corp Warrants, each whole warrant exercisable for one Class A ordinary share at an ex
MOTV.WS
$65K 0.01%
+63,500
New +$81.9K
PNTM.WS
325
DELISTED
Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PNTM.WS
$64K 0.01%
72,105
-862
-1% -$693
11 12
13
14 15

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return

Advisory Research's Q4 2021 Portfolio in Review

As of Q4 2021, Advisory Research held 428 positions worth $1.27B, down 18% from $1.56B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Advisory Research withdrew a net $382M in Q4 2021, closing 77 positions and reducing 156 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $11M position sold in full.

By sector, the portfolio is most concentrated in Energy at 31% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Advisory Research opened a new position in Moelis & Co worth $4.4M.

  • Advisory Research's largest Q4 2021 buy was Moelis & Co: 70,442 shares worth $4.4M.
  • Advisory Research added most to Coterra Energy in Q4 2021, an estimated $26.5M increase.
  • Advisory Research's biggest Q4 2021 reduction was EQT Corp, cutting an estimated $38.2M.
  • Advisory Research fully exited Terminix Global Holdings, Inc. in Q4 2021, selling an estimated $11M.
  • Advisory Research's ten largest holdings make up 34% of its $1.27B portfolio in Q4 2021.
  • Advisory Research opened 73 new positions and closed 77 in Q4 2021.
  • Advisory Research's portfolio value fell 18% quarter-over-quarter to $1.27B.

Based on Advisory Research's 13F filing for Q4 2021, filed 11 Feb 2022.